Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...
GlobalData on MSN17h
Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemiaHealth Canada has approved Novartis Canada’s Fabhalta (iptacopan capsules) as the first oral monotherapy to treat adults with ...
Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the fourth quarter and 12 months ended 31 December ...
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread ...
7h
Hosted on MSNEU reshapes HTAs: is the industry ready for it?New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
In statements and interviews with The Crimson, nine life sciences researchers at Harvard — from the Harvard School of Public ...
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...
21hon MSN
Republicans are trying to exclude people who are in the U.S. illegally from the numbers used to portion out congressional ...
The paper reviews some of the major issues that occur in the application of big data analytics and predictive modeling in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results